KRAS and neoplasm: To test whether tumour‐intrinsic PI3Kα could be involved in this tumour/stroma interaction, we used derived cell lines from tumoural lesions induced either by Kras mutant or Kras mutant in pancreatic cells partly lacking PI3Kα activity, presenting differential metastatic potential (Fig 6N).